Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Background Multiparametric magnetic resonance imaging (MRI), with or without MRI‐
targeted biopsy, is an alternative test to systematic transrectal ultrasonography‐guided …

Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Background Data on the efficacy and safety of screening for prostate cancer with magnetic
resonance imaging (MRI) are needed from studies of follow-up screening. Methods In a …

Background The use of 12-core systematic prostate biopsy is associated with diagnostic
inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer …

Context Magnetic resonance imaging (MRI), with or without MRI-targeted biopsy (MRI
pathway), is an alternative test to systematic transrectal ultrasonography-guided biopsy in …

Context: Prebiopsy multiparametric magnetic resonance imaging (mpMRI) is increasingly
used in prostate cancer diagnosis. The reported negative predictive value (NPV) of mpMRI …

Background Prostate-specific antigen (PSA) is a commonly used test to detect prostate
cancer. Attention has mostly focused on the use of PSA in screening asymptomatic patients …

Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …

Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …